 | Up a level |
Dziadziuszko, Rafal; Smit, Egbert F; Dafni, Urania; Wolf, Juergen; Wasąg, Bartosz; Biernat, Wojciech; Finn, Stephen P; Kammler, Roswitha; Tsourti, Zoi; Rabaglio, Manuela; Ruepp, Barbara; Roschitzki-Voser, Heidi; Stahel, Rolf A; Felip, Enriqueta; Peters, Solange (2019). Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP). Journal of thoracic oncology, 14(6), pp. 1086-1094. Elsevier 10.1016/j.jtho.2019.02.017
Peters, Solange; Stahel, Rolf A; Dafni, Urania; Aix, Santiago Ponce; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Noguera, Javier Garde; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen Mj; Vidal, Óscar Juan; ... (2017). Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of thoracic oncology, 12(4), pp. 752-762. Elsevier 10.1016/j.jtho.2016.12.017
Kotov, Ilya N; Siebring-van Olst, Ellen; Knobel, Philip A; van der Meulen-Muileman, Ida H; Felley-Bosco, Emanuela; van Beusechem, Victor W; Smit, Egbert F; Stahel, Rolf A; Marti, Thomas (2014). Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress. Molecular oncology, 8(8), pp. 1747-1759. Elsevier 10.1016/j.molonc.2014.07.008
Swarts, Dorian R A; Claessen, Sandra M H; Jonkers, Yvonne M H; van Suylen, Robert-Jan; Dingemans, Anne-Marie C; de Herder, Wouter W; de Krijger, Ronald R; Smit, Egbert F; Thunnissen, Frederik B J M; Seldenrijk, Cornelis A; Vink, Aryan; Perren, Aurel; Ramaekers, Frans C S; Speel, Ernst-Jan M (2011). Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome. American journal of pathology, 179(3), pp. 1129-37. New York, N.Y.: Elsevier 10.1016/j.ajpath.2011.05.028
